ロード中...
BRAF-targeted therapy and immune responses to melanoma
Type I BRAF inhibitors and immunotherapy constitute two new exciting approaches for the treatment of advanced malignant melanoma. We have recently elucidated a role for host C-C chemokine receptor type 2 (CCR2) in the antineoplastic effects of type I BRAF inhibitors in mice, supporting the therapeut...
保存先:
| 主要な著者: | , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Landes Bioscience
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3716742/ https://ncbi.nlm.nih.gov/pubmed/23894707 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/onci.24462 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|